edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Associated equity: Recce Pharmaceuticals
Recce Pharmaceuticals is developing novel, broad-spectrum synthetic polymer anti-infective drugs for the treatment of several infectious diseases, including sepsis, burn wound infections, urinary tract infections/urosepsis and diabetic foot infections.
Recce Pharmaceuticals — 6 videos in collection
Recce Pharmaceuticals (ASX:RCE) hosted an investor webinar on 19 March 2026, providing an update across its anti-infective portfolio.
The webinar features presentations from key speakers covering major program areas, including:
Recce is developing a new class of synthetic anti-infectives designed to address the growing global challenge of antimicrobial resistance.
Get access to the very latest content matched to your personal investment style.